Orfi L - Search Results

1

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties.

Hegedus C, Ozvegy-Laczka C, Apáti A, Magócsi M, Német K, Orfi L, Kéri G, Katona M, Takáts Z, Váradi A, Szakács G, Sarkadi B. Hegedus C, et al. Among authors: orfi l. Br J Pharmacol. 2009 Oct;158(4):1153-64. doi: 10.1111/j.1476-5381.2009.00383.x. Epub 2009 Sep 28. Br J Pharmacol. 2009. PMID: 19785662 Free PMC article.

2

Characterization of binding mode of imatinib to human α1-acid glycoprotein.

Fitos I, Simon Á, Zsila F, Mády G, Bencsura Á, Varga Z, Orfi L, Kéri G, Visy J. Fitos I, et al. Among authors: orfi l. Int J Biol Macromol. 2012 Apr 1;50(3):788-95. doi: 10.1016/j.ijbiomac.2011.11.023. Epub 2011 Nov 29. Int J Biol Macromol. 2012. PMID: 22142793

3

Heterocondensed quinazolones: synthesis and protein-tyrosine kinase inhibitory activity of 3,4-dihydro-1H,6H-[1,4] oxazino-[3,4-b]quinazolin-6-one derivatives.

Orfi L, Kökösi J, Szász G, Kövesdi I, Mák M, Teplán I, Kéri G. Orfi L, et al. Bioorg Med Chem. 1996 Apr;4(4):547-51. doi: 10.1016/0968-0896(96)00040-5. Bioorg Med Chem. 1996. PMID: 8735842

4

Novel, selective CDK9 inhibitors for the treatment of HIV infection.

Németh G, Varga Z, Greff Z, Bencze G, Sipos A, Szántai-Kis C, Baska F, Gyuris A, Kelemenics K, Szathmáry Z, Minárovits J, Kéri G, Orfi L. Németh G, et al. Among authors: orfi l. Curr Med Chem. 2011;18(3):342-58. doi: 10.2174/092986711794839188. Curr Med Chem. 2011. PMID: 21143121

5

Tyrphostin induces non-apoptotic programmed cell death in colon tumor cells.

Szende B, Kéri G, Szegedi Z, Benedeczky I, Csikós A, Orfi L, Gazit A. Szende B, et al. Among authors: orfi l. Cell Biol Int. 1995 Nov;19(11):903-11. doi: 10.1006/cbir.1995.1028. Cell Biol Int. 1995. PMID: 8574217

6

Prediction oriented QSAR modelling of EGFR inhibition.

Szántai-Kis C, Kövesdi I, Eros D, Bánhegyi P, Ullrich A, Kéri G, Orfi L. Szántai-Kis C, et al. Among authors: orfi l. Curr Med Chem. 2006;13(3):277-87. doi: 10.2174/092986706775476098. Curr Med Chem. 2006. PMID: 16475937

7

Pro-apoptotic and anti-apoptotic molecules affecting pathways of signal transduction.

Kéri G, Racz G, Magyar K, Orfi L, Horváth A, Schwab R, Hegymegi BB, Szende B. Kéri G, et al. Among authors: orfi l. Ann N Y Acad Sci. 2003 Dec;1010:109-12. doi: 10.1196/annals.1299.018. Ann N Y Acad Sci. 2003. PMID: 15033704

8

Inhibition of c-Met with the specific small molecule tyrosine kinase inhibitor SU11274 decreases growth and metastasis formation of experimental human melanoma.

Kenessey I, Keszthelyi M, Krámer Z, Berta J, Adám A, Dobos J, Mildner M, Flachner B, Cseh S, Barna G, Szokol B, Orfi L, Kéri G, Döme B, Klepetko W, Tímár J, Tóvári J. Kenessey I, et al. Among authors: orfi l. Curr Cancer Drug Targets. 2010 May;10(3):332-42. doi: 10.2174/156800910791190184. Curr Cancer Drug Targets. 2010. PMID: 20370683

9

Pharmacophore and binding analysis of known and novel B-RAF kinase inhibitors.

Baska F, Szabadkai I, Sipos A, Breza N, Szántai-Kis C, Kékesi L, Garamvölgyi R, Nemes Z, Baska F, Neumann L, Torka R, Ullrich A, Kéri G, Orfi L. Baska F, et al. Among authors: orfi l. Curr Med Chem. 2014 Jun;21(17):1938-55. doi: 10.2174/0929867321666140304152606. Curr Med Chem. 2014. PMID: 24606495

10

[Preparation and characterization of potential antineoplastic agents].

Orfi L, Wáczek F, Szabó M, Kövesdi I, Mészáros G, Idei M, Horváth A, Hollósy F, Mák M, Szegedi Z, Szende B, Kéri G, Noszál B. Orfi L, et al. Acta Pharm Hung. 1999 Jun;69(3):115-22. Acta Pharm Hung. 1999. PMID: 10401154 Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters